Oral immunotherapy with grass pollen in enterosoluble capsules
- 1 May 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 149 (8) , 545-550
- https://doi.org/10.1007/bf01957689
Abstract
In a prospective study spanning 2 years, 60 patients with grass pollen allergy were treated with either a low dose oral, a high dose oral or a subcutaneous hyposensitization regime. No significant improvement was seen in the orally treated patients whereas those on the subcutaneous hyposensitization regime demonstrated a decreased specific cutaneous reactivity, a rise in specific IgG antibodies and a reduction in symptoms. This study suggests that oral hyposensitization, even with enterosoluble grass pollen capsules, is ineffective.This publication has 21 references indexed in Scilit:
- A controlled trial of oral hyposensitization in pollen asthma and rhinitis in childrenClinical and Experimental Allergy, 1984
- Grass pollen immunotherapy: A single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitisJournal of Allergy and Clinical Immunology, 1984
- A double-blind histamine placebo—controlled trial of polymerized whole grass for immunotherapy of grass allergyJournal of Allergy and Clinical Immunology, 1983
- Untersuchungen zur Wirksamkeit oraler und parenteraler Hyposensibilisierung mit Pollen-ExtraktenDeutsche Medizinische Wochenschrift (1946), 1983
- Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: A six-year prospective studyJournal of Allergy and Clinical Immunology, 1982
- Controlled evaluation of allergoid in the immunotherapy of ragweed hay feverJournal of Allergy and Clinical Immunology, 1982
- Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapyJournal of Allergy and Clinical Immunology, 1982
- A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergyJournal of Allergy and Clinical Immunology, 1982
- Clinical and immunologic evaluation of glutaraldehyde-modified, tyrosine-adsorbed short ragweed extract: a double-blind, placebo-controlled trialJournal of Allergy and Clinical Immunology, 1981
- Immunologic and cellular changes accompanying the therapy of pollen allergyJournal of Clinical Investigation, 1971